e424b3
Filed
under Rule 424(b)(3) and (7) of the Securities Act of 1933,
relating to Registration No. 333-132865
Supplement
No. 1 to Prospectus Supplement Dated March 31, 2006
and
Prospectus Dated March 30, 2006
Intel Corporation
$1,600,000,000
2.95% Junior Subordinated Convertible Debentures due 2035
And
Shares of Common Stock Issuable Upon Conversion of the Debentures
This
supplement no. 1 to the prospectus supplement dated March 31,
2006 and the prospectus dated March 30, 2006 relates to the
resale by selling securityholders of Intel Corporations 2.95% Junior Subordinated Convertible
Debentures Due 2035 and the shares of Intel common stock issuable upon conversion of the
debentures.
You should read this supplement no. 1 in conjunction with the prospectus supplement dated
March 31, 2006 and the prospectus dated March 30, 2006, which should be delivered in conjunction
with this supplement no. 1. This supplement no. 1 is not complete without, and may not be delivered
or used except in conjunction with, the prospectus and prospectus supplement, including any
amendments or supplements to them. This supplement no. 1 is qualified by reference to the
prospectus supplement and the prospectus, except to the extent that the information provided by this supplement no. 1
supercedes information contained in the prospectus supplement.
Investing in the debentures and the common stock issuable upon conversion of the debentures
involves risk. See the discussion entitled Risk Factors beginning on page S-5 of the prospectus
supplement dated March 31, 2006.
Neither the Securities and Exchange Commission nor any state securities commission has
approved or disapproved of these securities or passed upon the adequacy or accuracy of this
supplement no. 1, the prospectus supplement dated March 31, 2006
or the prospectus dated March 30, 2006. Any representation to the
contrary is a criminal offense.
The table under the caption Selling Securityholders beginning on page S-54 of the prospectus
supplement is hereby supplemented and amended by updating information as to certain selling
securityholders identified in the table below and adding to it certain selling securityholders
identified in the table below. We prepared this table based on information supplied to us by the
selling securityholders named in the table below on or prior to April 28, 2006. Information about the selling securityholders may change over time. If required, any changed
or new information given to us will be set forth in supplements to the prospectus supplement or
amendments to the registration statement of which the prospectus,
prospectus supplement and supplement no. 1 are a part, if and when necessary.
We have assumed for purposes of the table below that the selling securityholders will sell all
of the debentures and all of the common stock issuable upon
conversion of the debentures pursuant to this
supplement no. 1, the prospectus supplement and the prospectus, and that any other shares of our
common stock beneficially owned by the selling securityholders will continue to be beneficially
owned.
Except as set forth below, none of the selling securityholders has, or within the past three
years has had, any position, office or other material relationship with us or any of our
predecessors or affiliates.
The selling securityholders identified below may have sold, transferred or otherwise disposed
of, pursuant to transactions exempt from the registration requirements of the Securities Act of
1933, as amended, all or a portion of their debentures since the date on which they provided the
information regarding their debentures.
Selling securityholders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Shares of |
|
|
|
|
|
|
Principal Amount of |
|
|
|
|
|
|
Number of Shares of |
|
|
Common Stock |
|
|
|
|
|
|
Debentures |
|
|
Percentage of |
|
|
Common Stock |
|
|
Beneficially Owned |
|
|
Natural Person(s) |
|
|
|
Beneficially Owned |
|
|
Debentures |
|
|
Issuable that May |
|
|
after the |
|
|
with Voting or |
|
Name of Selling Securityholder (1) |
|
and Offered (USD) |
|
|
Outstanding (%) |
|
|
Be Sold(2)(3) |
|
|
Offering(4) |
|
|
Investment Power |
|
Alcon 401(k) Retirement Plan |
|
|
720,000 |
|
|
|
* |
|
|
|
22,835 |
|
|
|
0 |
|
|
Gene T. Pretti |
American Founders Life Insurance Company |
|
|
300,000 |
|
|
|
* |
|
|
|
9,514 |
|
|
|
0 |
|
|
Gene T. Pretti |
Arkansas PERS (5) |
|
|
2,780,000 |
|
|
|
* |
|
|
|
88,171 |
|
|
|
0 |
|
|
Ann Houlihan |
AstraZeneca Holdings Pension (6) |
|
|
355,000 |
|
|
|
* |
|
|
|
11,259 |
|
|
|
0 |
|
|
Ann Houlihan |
Banc of
America Securities LLC (#) |
|
|
10,000,000 |
|
|
|
* |
|
|
|
317,162 |
|
|
|
0 |
|
|
(7) |
Bancroft
Fund Ltd. (8) |
|
|
1,500,000 |
|
|
|
* |
|
|
|
47,574 |
|
|
|
0 |
|
|
(9) |
Blue Cross Blue Shield of Louisiana |
|
|
1,300,000 |
|
|
|
* |
|
|
|
41,231 |
|
|
|
0 |
|
|
Gene T. Pretti |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Canyon Capital Arbitrage Master Fund, Ltd.(+) |
|
|
4,950,000 |
|
|
|
* |
|
|
|
156,995 |
|
|
|
0 |
|
|
(10) |
Canyon Value Realization Fund, L.P. (+) |
|
|
2,550,000 |
|
|
|
* |
|
|
|
80,876 |
|
|
|
0 |
|
|
(11) |
Canyon Value Realization MAC 18, Ltd. (RMF)
(+) |
|
|
750,000 |
|
|
|
* |
|
|
|
23,787 |
|
|
|
0 |
|
|
(12) |
Catholic Mutual Relief Society of America |
|
|
300,000 |
|
|
|
* |
|
|
|
9,514 |
|
|
|
0 |
|
|
Gene T. Pretti |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Catholic Relief Insurance Company of America |
|
|
200,000 |
|
|
|
* |
|
|
|
6,343 |
|
|
|
0 |
|
|
Gene T. Pretti |
CNHCA Master Account, L.P. |
|
|
25,000,000 |
|
|
|
1.56 |
% |
|
|
792,905 |
|
|
|
0 |
|
|
(13) |
Coda Capital Mgmt |
|
|
740,000 |
|
|
|
* |
|
|
|
23,469 |
|
|
|
0 |
|
|
Jeremiah P. OGrady |
Coda Capital ND Acct |
|
|
400,000 |
|
|
|
* |
|
|
|
12,686 |
|
|
|
0 |
|
|
Jeremiah P. OGrady |
Coda-KHPE Convertible |
|
|
900,000 |
|
|
|
* |
|
|
|
28,544 |
|
|
|
0 |
|
|
Jeremiah P. OGrady |
Continental Assurance Company on behalf of
its separate account (E) (+) |
|
|
1,600,000 |
|
|
|
* |
|
|
|
50,745 |
|
|
|
0 |
|
|
(14) |
Delaware PERS (15) |
|
|
2,175,000 |
|
|
|
* |
|
|
|
68,982 |
|
|
|
0 |
|
|
Ann Houlihan |
Dow Employees Pension Plan |
|
|
1,200,000 |
|
|
|
* |
|
|
|
38,059 |
|
|
|
0 |
|
|
Gene T. Pretti |
Elizabeth D Bruce Tr |
|
|
80,000 |
|
|
|
* |
|
|
|
2,537 |
|
|
|
0 |
|
|
Jeremiah P. OGrady |
Gartmore Conv. Fund |
|
|
2,045,000 |
|
|
|
* |
|
|
|
64,859 |
|
|
|
0 |
|
|
Jeremiah P. OGrady |
ICI American
Holdings Trust (16) |
|
|
615,000 |
|
|
|
* |
|
|
|
19,505 |
|
|
|
0 |
|
|
Ann Houlihan |
James Mellon Tr |
|
|
65,000 |
|
|
|
* |
|
|
|
2,061 |
|
|
|
0 |
|
|
Jeremiah P. OGrady |
JPMorgan Securities Inc. (#) |
|
|
53,000,000 |
|
|
|
3.31 |
% |
|
|
1,680,958 |
|
|
|
10,647,017 |
|
|
(17) |
LDG Limited |
|
|
1,036,000 |
|
|
|
* |
|
|
|
32,857 |
|
|
|
0 |
|
|
(18) |
LeeDavid Investments |
|
|
60,000 |
|
|
|
* |
|
|
|
1,902 |
|
|
|
0 |
|
|
Jeremiah P. OGrady |
Lehman
Brothers Inc. (#) |
|
|
4,000,000 |
|
|
|
* |
|
|
|
126,864 |
|
|
|
0 |
|
|
(19) |
MAG Mutual Insurance Company |
|
|
550,000 |
|
|
|
* |
|
|
|
17,443 |
|
|
|
0 |
|
|
Gene T. Pretti |
NAMIC Insurance Company |
|
|
10,000 |
|
|
|
* |
|
|
|
317 |
|
|
|
0 |
|
|
Gene T. Pretti |
NMIC Convertible Port |
|
|
3,020,000 |
|
|
|
* |
|
|
|
95,782 |
|
|
|
0 |
|
|
Jeremiah P. OGrady |
Nuveen
Preferred & Convertible Fund JPC (20) |
|
|
9,775,000 |
|
|
|
* |
|
|
|
310,025 |
|
|
|
0 |
|
|
Ann Houlihan |
Nuveen
Preferred & Convertible Fund JQC (21) |
|
|
13,625,000 |
|
|
|
* |
|
|
|
432,133 |
|
|
|
0 |
|
|
Ann Houlihan |
Oak Hill Contingent Capital Fund Ltd. |
|
|
10,000,000 |
|
|
|
* |
|
|
|
317,162 |
|
|
|
343,370 |
|
|
(22) |
OB Pension Gartmore |
|
|
810,000 |
|
|
|
* |
|
|
|
25,690 |
|
|
|
0 |
|
|
Jeremiah P. OGrady |
Physicians Mutual Insurance Company |
|
|
400,000 |
|
|
|
* |
|
|
|
12,686 |
|
|
|
0 |
|
|
Gene T. Pretti |
PIMCO Convertible Fund |
|
|
300,000 |
|
|
|
* |
|
|
|
9,514 |
|
|
|
0 |
|
|
Mark Hadoff |
Prudential
Insurance Co. of America (+) (23) |
|
|
160,000 |
|
|
|
* |
|
|
|
5,074 |
|
|
|
0 |
|
|
Ann Houlihan |
Qwest Occupational Health Trust |
|
|
180,000 |
|
|
|
* |
|
|
|
5,708 |
|
|
|
0 |
|
|
Gene T. Pretti |
Qwest Pension Trust |
|
|
1,030,000 |
|
|
|
* |
|
|
|
32,667 |
|
|
|
0 |
|
|
Gene T. Pretti |
Richard Mueller |
|
|
80,000 |
|
|
|
* |
|
|
|
2,537 |
|
|
|
0 |
|
|
Jeremiah P. OGrady |
Stanfield Offshore Leveraged Assets, Ltd. |
|
|
17,500,000 |
|
|
|
* |
|
|
|
555,033 |
|
|
|
0 |
|
|
(24) |
State of
Oregon Equity (25) |
|
|
8,000,000 |
|
|
|
* |
|
|
|
253,729 |
|
|
|
0 |
|
|
Ann Houlihan |
T. Rowe
Price Value Fund, Inc. (+) (26) |
|
|
12,250,000 |
|
|
|
* |
|
|
|
388,523 |
|
|
|
2,490,000 |
|
|
(27) |
The Canyon Value Realization Fund (Cayman),
Ltd. (+) |
|
|
6,750,000 |
|
|
|
* |
|
|
|
214,084 |
|
|
|
0 |
|
|
(28) |
Union Carbide Employees Pension Plan |
|
|
520,000 |
|
|
|
* |
|
|
|
16,492 |
|
|
|
0 |
|
|
Gene T. Pretti |
Van Eck WWARF |
|
|
100,000 |
|
|
|
* |
|
|
|
3,171 |
|
|
|
0 |
|
|
Jeremiah P. OGrady |
Virgina Retirement System |
|
|
5,400,000 |
|
|
|
* |
|
|
|
171,267 |
|
|
|
0 |
|
|
Gene T. Pretti |
Zazove Institutional Investment Grade
Convertible Fund, L.P. |
|
|
3,000,000 |
|
|
|
* |
|
|
|
95,148 |
|
|
|
0 |
|
|
Gene T. Pretti |
S-2
* Less than one percent (1%).
# The selling securityholder is a registered broker-dealer.
+ The selling securityholder is an affiliate of a registered broker-dealer.
(1) Information concerning other selling securityholders will be set forth in additional
supplements to the prospectus supplement from time to time, if required.
(2) Assumes conversion of all of the holders debentures at a conversion rate of 31.7162 shares of
common stock per $1,000 principal amount at maturity of the debentures. This conversion rate is
subject to adjustment as described under Description of debenturesConversion rights in the
prospectus supplement. As a result, the number of shares of common stock issuable upon conversion
of the debentures may increase or decrease in the future. Excludes shares of common stock that may
be issued by us upon the repurchase of the debentures as described under Description of
debenturesFundamental change permits holders to require us to repurchase debentures and
fractional shares. Holders will receive a cash adjustment for any fractional share amount resulting
from conversion of the debentures, as described under Description of debenturesConversion
rights.
(3) Calculated based on Rule 13d-3(d)(i) of the Exchange Act. The number of shares of common stock
beneficially owned by each holder named above is less than 1% of our outstanding common stock
calculated based on 5,883 million shares of common stock outstanding as of January 27, 2006. In
calculating this amount for each holder, we treated as outstanding the number of shares of common
stock issuable upon conversion of all of that holders debentures, but we did not assume conversion
of any other holders debentures.
(4) For purposes of computing the number and percentage of debentures and shares of common stock to
be held by the selling securityholders after the conclusion of the offering, we have assumed for
purposes of the table above that the selling securityholders named above will sell all of the
debentures and all of the common stock issuable upon conversion of the debentures offered by this
prospectus, and that any other shares of our common stock beneficially owned by these selling
securityholders will continue to be beneficially owned.
(5) This
selling securityholder was previously listed as holding $2,405,000 in principal amount of
the debentures. The information included in this supplement no. 1 supercedes all prior information
concerning Arkansas PERS.
(6) This
selling securityholder was previously listed as holding $305,000 in principal amount of the
debentures. The information included in this supplement no. 1 supercedes all prior information
concerning AstraZeneca Holdings Pension.
(7) Bank of America Corporation has control over the securities held by Banc of America Securities
LLC. Bank of America Corporation is a public company and listed on the NYSE.
(8) The
selling securityholder was previously listed incorrectly as Bancroft Fund, Inc. The
correct name of the selling securityholder is as listed herein.
(9) Bancroft Fund Ltd. is a publicly traded company.
(10) Canyon Capital Advisors LLC is the controlling entity with voting and investment power for
Canyon Capital Arbitrage Master Fund, Ltd. Canyon Capital Advisors LLC is the investment advisor
for Canyon Capital Arbitrage Master Fund, Ltd. and has the power to direct investments by Canyon
Capital Arbitrage Master Fund, Ltd.. The managing partners of Canyon Capital Advisors LLC are
Joshua Friedman, Mitchell R. Julis and K. Robert Turner. Canyon Capital Arbitrage Master Fund,
Ltd. is a Cayman Islands Exempted company.
(11) Canpartners
Investments III, L.P. and Canyon Capital Advisors LLC are the controlling entities
with voting and investment power for Canyon Value Realization Fund, L.P. The general partners for
Canyon Value Realization Fund, L.P. are Canpartners Investments III, L.P. and Canyon Capital
Advisors LLC. Canyon Capital Advisors LLC is the general partner of Canpartners Investments III.
The managing partners of Canyon Capital Advisors LLC are Joshua S. Friedman, Mitchell R. Julis and
K. Robert Turner.
S-3
(12) RMF MAC Ltd. is the controlling entity with voting and investment power for Canyon Value
Realization MAC 18, Ltd. (RMF). Managed Accounts Limited is the parent company of Canyon Value
Realization MAC 18, Ltd. Canyon Capital Advisors is the investment advisor for Canyon Value
Realization MAC 18, Ltd. and has the power to direct investments. The managing partners of Canyon
Capital Advisors LLC are Joshua Friedman, Mitchell R. Julis and K. Robert Turner. Canyon Value
Realization MAC 18, Ltd. is a Limited Liability Cayman Islands company.
(13) CNH Partners, LLC is Investment Advisor of the selling securityholder and has sole voting and
dispositive power over the registrable securities. Investment principals for the advisor are Robert Krail,
Mark Mitchell and Todd Pulvino.
(14) Continental Assurance Company is an affiliate of CNA, a publicly traded company.
(15) This
selling securityholder was previously listed as holding $1,835,000 in principal amount of
the debentures. The information included in this supplement no. 1 supercedes all prior information
concerning Delaware PERS.
(16) This
selling securityholder was previously listed as holding $535,000 in
principal amount of the debentures. The information included in this
supplement no. 1 supercedes all prior information concerning ICI
American Holdings Trust.
(17) JPMorgan Securities Inc. is a wholly-owned subsidiary of JPMorgan Chase & Co., which is
a publicly traded company listed on the NYSE.
(18) TQA Investors LLC has sole investment power and shared voting power for the securities held by
LDG Limited. Its members are Robert Butman, John Idone, George Esser, Paul Bucci and Bartholomew
Tesoreiro.
(19) The selling securityholder is a subsidiary of Lehman Brothers Holdings, a publicly traded
entity.
(20) This
selling securityholder was previously listed as holding $8,540,000 in
principal amount of the debentures. The information included in this
supplement no. 1 supercedes all prior information concerning
Nuveen Preferred & Convertible Fund JPC.
(21) This
selling securityholder was previously listed as holding $11,880,000
in principal amount of the debentures. The information included in
this supplement no. 1 supercedes all prior information
concerning Nuveen Preferred & Convertible Fund JQC.
(22) The persons with voting and investment control over the securities held by Oak Hill
Contingent Capital Fund Ltd. are the members of Oak Hill Platinum Partners, L.L.C.s Capital
Allocation Committee, who are Steven Goldberg, Ayman Hindy, Chi-fu Huang, Myron Scholes and
Tong-sheng Sun, each of whom disclaims beneficial ownership of the securities being registered.
(23) This
selling securityholder was previously listed as holding $135,000 in
principal amount of the debentures. The information included in this
supplement no. 1 supercedes all prior information concerning
Prudential Insurance Co. of America.
(24) The beneficial holder of the securities is Stanfield Offshore Leveraged Assets, Ltd. (SOLA),
a Cayman Islands exempted company. The investment manager of SOLA is Stanfield Capital Partners
LLC, a New York limited liability company, which is an investment adviser registered with the U.S.
Securities and Exchange Commission under the Investment Advisers Act of 1940, as amended. The
members of the management committee of Stanfield Capital Partners LLC are Dan Baldwin, Steve
Alfieri, Chris Jansen, Sarah Street and Chris Greetham. Each member disclaims beneficial ownership
of the securities owned by SOLA.
(25) This
selling securityholder was previously listed as holding $6,900,000 in
principal amount of the debentures. The information included in this
supplement no. 1 supercedes all prior information concerning
State of Oregon Equity.
(26) This
selling securityholder was previously listed as holding $12,000,000 in principal amount of
the debentures. The information included in this supplement no. 1 supercedes all prior information
concerning T. Rowe Price Value Fund, Inc.
(27) T. Rowe Price Associates, Inc. (T. Rowe Price Associates) serves as an investment adviser
with the power to direct investments and/or sole power to vote the shares owned by the funds and
accounts to which this footnote applies, as well as shares owned by certain other individual and
institutional investors. For purposes of the reporting requirements of the Securities Exchange Act
of 1934, T. Rowe Price Associates may be deemed to be the beneficial owner of all of the shares
listed in this table and to which this footnote applies; however, T. Rowe Price Associates
expressly disclaims that it is, in fact, the beneficial owner of such securities. T. Rowe Price
Associates is a wholly owned subsidiary of T. Rowe Price Group, Inc., which is a publicly traded
financial services holding company.
(28) Canyon Capital Advisors LLC is the investment advisor for the The Canyon Value Realization
Rund (Cayman), Ltd and is the controlling entity with voting power. The managing partners of
Canyon Capital Advisors LLC are Joshua S. Friedman, Mitchell R. Julis and K. Robert Turner. In
addition, Joshua S. Friedman, Mitchell R. Julis and R. Christian B. Evensen own all of the ordinary
shares of Canyon Value Realization Fund (Cayman), Ltd., carrying full voting rights on all matters.
S-4
Only selling securityholders identified above who beneficially own the securities set forth
opposite each such selling securityholders name in the foregoing table may sell such securities
under the registration statement. Prior to any use of this prospectus in connection with an
offering of the debentures and/or the underlying common stock by any holder not identified above,
this supplement no.1 will be supplemented to set forth the name and other information about the
selling securityholder intending to sell such debentures and the underlying common stock.
The date
of the supplement no. 1 is May 2, 2006
S-5